184 related articles for article (PubMed ID: 3785584)
1. The effects of physostigmine on acetylcholinesterase activity of CSF plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs.
Mattio T; McIlhany M; Giacobini E; Hallak M
Neuropharmacology; 1986 Oct; 25(10):1167-77. PubMed ID: 3785584
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of two inhibitors on brain cholinesterase.
Hallak M; Giacobini E
Neuropharmacology; 1987 Jun; 26(6):521-30. PubMed ID: 3601008
[TBL] [Abstract][Full Text] [Related]
3. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
Giacobini E; Somani S; McIlhany M; Downen M; Hallak M
Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
[TBL] [Abstract][Full Text] [Related]
5. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
Wetherell JR
J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
7. Effect of cholinesterase inhibitor and exercise on choline acetyltransferase and acetylcholinesterase activities in rat brain regions.
Somani SM; Babu SR; Arneric SP; Dube SN
Pharmacol Biochem Behav; 1991 Jun; 39(2):337-43. PubMed ID: 1946575
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.
Laganière S; Corey J; Tang XC; Wülfert E; Hanin I
Neuropharmacology; 1991 Jul; 30(7):763-8. PubMed ID: 1922687
[TBL] [Abstract][Full Text] [Related]
9. Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.
Hallak M; Giacobini E
Neurochem Res; 1986 Jul; 11(7):1037-48. PubMed ID: 3748273
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of human cerebral acetylcholinesterase.
Pappata S; Tavitian B; Traykov L; Jobert A; Dalger A; Mangin JF; Crouzel C; DiGiamberardino L
J Neurochem; 1996 Aug; 67(2):876-9. PubMed ID: 8764619
[TBL] [Abstract][Full Text] [Related]
11. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
[TBL] [Abstract][Full Text] [Related]
12. Central injection of physostigmine attenuates exercise-induced pressor response in conscious cats.
Ally A; Hand GA; Mitchell JH
Am J Physiol; 1997 Jul; 273(1 Pt 2):R393-9. PubMed ID: 9249577
[TBL] [Abstract][Full Text] [Related]
13. Cholinotoxicity induced by ethylcholine aziridinium ion after intracarotid and intracerebroventricular administration.
Pittel Z; Fisher A; Heldman E
Life Sci; 1989; 44(20):1437-48. PubMed ID: 2725177
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects elicited by central administration of physostigmine via M2 muscarinic receptors in conscious cats.
Ally A; Wilson LB; Nóbrega AC; Mitchell JH
Brain Res; 1995 Apr; 677(2):268-76. PubMed ID: 7552252
[TBL] [Abstract][Full Text] [Related]
15. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Leventer SM; Wulfert E; Hanin I
Neuropharmacology; 1987 Apr; 26(4):361-5. PubMed ID: 3587537
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of acetylcholine in different brain regions in vivo following alternative methods of sacrifice by microwave irradiation.
Nordberg A; Sundwall A
Acta Physiol Scand; 1976 Nov; 98(3):307-17. PubMed ID: 998280
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of central administration of cholinomimetics in anesthetized cats.
Ally A; Hara Y; Murayama S
Neuropharmacology; 1993 Feb; 32(2):185-93. PubMed ID: 7680786
[TBL] [Abstract][Full Text] [Related]
18. Modulation of acetylcholine release by nicotinic receptors in the rat brain.
De Sarno P; Giacobini E
J Neurosci Res; 1989 Feb; 22(2):194-200. PubMed ID: 2709442
[TBL] [Abstract][Full Text] [Related]
19. Effects of hexamethonium, phenothiazines, propranolol and ephedrine on acetylcholinesterase carbamylation by physostigmine, aldicarb and carbaryl: interaction between the active site and the functionally distinct peripheral sites in acetylcholinesterase.
Singh AK; Spassova D
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jan; 119(1):97-105. PubMed ID: 9568379
[TBL] [Abstract][Full Text] [Related]
20. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
